Hera Biotech, Inc., a biotechnology firm based in San Antonio, TX, has filed an SEC Form D indicating a successful fundraising effort. The company raised $796,000 of a total offering amount of $5 million through debt securities.
Related articles
Press ReleaseJune 19, 2026
Discovery 2026 Short Duration LP Initial Public Offering – Maximum $35,000,000
June 19, 2026
Press ReleaseJune 19, 2026
FULL CIRCLE LITHIUM ANNOUNCES $5.0 MILLION NON-BROKERED PRIVATE PLACEMENT
June 19, 2026
Press ReleaseJune 19, 2026
LUMIQ Raises Strategic Funding to Become the AI Decision Layer for Financial Services
June 19, 2026
← Back to all articles
Generated by Olivia 6